These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30514477)

  • 1. Management of normal tension glaucoma.
    Gittinger JW
    Surv Ophthalmol; 2019; 64(1):101. PubMed ID: 30514477
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraocular pressure-independent management of normal tension glaucoma.
    Adeghate J; Rahmatnejad K; Waisbourd M; Katz LJ
    Surv Ophthalmol; 2019; 64(1):101-110. PubMed ID: 30300625
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing normal tension glaucoma by lowering the intraocular pressure.
    Razeghinejad MR; Lee D
    Surv Ophthalmol; 2019; 64(1):111-116. PubMed ID: 30300624
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term rate of progression and target intraocular pressure in patients with normal-tension glaucoma in clinical care.
    Bach-Holm D; Jensen PK; Kessing SV
    Acta Ophthalmol; 2018 Dec; 96(8):e1034-e1035. PubMed ID: 30259686
    [No Abstract]   [Full Text] [Related]  

  • 5. Brimonidine and eye pressure.
    Nowroozzadeh MH; Razeghinejad MR
    Ophthalmology; 2010 Jul; 117(7):1463; author reply 1463-4. PubMed ID: 20610002
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of intraocular pressure reduction on progression of normal-tension glaucoma with myopic tilted disc and associated risk factors.
    Seol BR; Kim S; Kim DM; Park KH; Jeoung JW; Kim SH
    Jpn J Ophthalmol; 2017 May; 61(3):230-236. PubMed ID: 28280945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preperimetric normal tension glaucoma study: long-term clinical course and effect of therapeutic lowering of intraocular pressure.
    Jeong JH; Park KH; Jeoung JW; Kim DM
    Acta Ophthalmol; 2014 May; 92(3):e185-93. PubMed ID: 24456145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure (IOP) reduction by latanoprost in Japanese normal tension glaucoma patients over a five-year period stratified by presenting IOP.
    Tsuda M; Ando A; Matsuyama K; Otsuji T; Fukui C; Maenishi N; Kuwahara A; Nishimura T; Jo N; Nambu H; Matsumura M
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):441-5. PubMed ID: 19857106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of normal tension glaucoma in Kearns-Sayre syndrome over 10 years.
    Zarnowski T; Kosior-Jarecka E
    Clin Exp Ophthalmol; 2012 Mar; 40(2):218-20. PubMed ID: 22004289
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years.
    Oie S; Ishida K; Yamamoto T
    Jpn J Ophthalmol; 2017 Jul; 61(4):314-323. PubMed ID: 28550431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
    Kim JM; Kim TW; Kim CY; Kim HK; Park KH
    Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Intraocular Pressure in a Patient With Septooptic Dysplasia: A Case Report.
    Ulloa-Padilla JP; Izquierdo NJ; Oliver A
    J Glaucoma; 2016 Jul; 25(7):e713-7. PubMed ID: 27136085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of corneal biomechanical properties in patients with progressive normal-tension glaucoma.
    Park JH; Jun RM; Choi KR
    Br J Ophthalmol; 2015 Jun; 99(6):746-51. PubMed ID: 25555704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure: is it a risk factor in normal tension glaucoma?
    Rao A
    J Glaucoma; 2015 Mar; 24(3):251-2. PubMed ID: 25333611
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent clinical pearls from clinical trials in glaucoma.
    Grover DS; Smith O
    Curr Opin Ophthalmol; 2012 Mar; 23(2):127-34. PubMed ID: 22249234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure measured by dynamic contour tonometer and ocular response analyzer in normal tension glaucoma.
    Chen Z; Xu G
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):607; author reply 609-10. PubMed ID: 20229612
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual and structural prognosis of the untreated fellow eyes of unilateral normal tension glaucoma patients.
    Cho HK; Suh W; Kee C
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1547-55. PubMed ID: 26126583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypertension and normal-tension glaucoma: time for banishment and burial.
    Sommer A
    Arch Ophthalmol; 2011 Jun; 129(6):785-7. PubMed ID: 21670346
    [No Abstract]   [Full Text] [Related]  

  • 20. Carnitine palmitoyl transferase II deficiency: a possible association with progression of normal pressure glaucoma.
    Singh R; Dubey R; Montfort J; Jeffries M; Agar A; Bank A; McNaught P; Francis IC
    Clin Exp Ophthalmol; 2012; 40(4):e237-8. PubMed ID: 21902793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.